Skip to content

Comparison of quality of bowel preparation regimens for colonoscopy: Low-volume Polyethylene glycol plus Ascorbic acid Solution (PEG-Asc), versus PEG-Asc plus Bisacodyl, and PEG-Asc plus Coffee

Comparison of quality of bowel preparation regimens for colonoscopy: Low-volume Polyethylene glycol plus Ascorbic acid Solution (PEG-Asc), versus PEG-Asc plus Bisacodyl, and PEG-Asc plus Coffee

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170512001
Enrollment
Unknown
Registered
2017-05-12
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient whom colonoscopy was indicated eg. CRC screening

Interventions

Subjects will receive 10 mg of bisacodyl then 1 L of PEG containing ascorbic acid at 5 am&#44
followed by an extra 500 ml of water.,Subjects will be instructed to dissolve coffee and PEG/Ascorbic acid in 1 L water and provided at 5 am&#44
followed by an extra 500 ml of water ,1 L of PEG containing ascorbic acid at 5 am&#44
followed by an extra 500 ml of water.
Active Comparator Drug,Active Comparator Drug,Active Comparator Drug
PEG with ascorbic acid plus bisacodyl ,PEG with ascorbic acid plus coffee,PEG with ascorbic acid

Sponsors

The Faculty of Medicine endownment Fund
Lead Sponsor
The Faculty of Medicine endownment Fund
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: -Patients, age 18-85 years, in whom colonoscopy was indicated -The subjects have provided written informed consents prior to admission the study

Exclusion criteria

Exclusion criteria: - Patients with the following conditions : ileus, intestinal obstruction or perforation, toxic megacolon, documented carcinoma, history of intestinal resection, or any other colonic disease leading to a fragile mucosa - Patients with NYHA grade III or IV congestive heart failure or history of congestive heart failure, history heart disease with poor LVEF, severe renal insufficiency (end-stage renal disease), known hypersensitivity to polyethylene glycol and/or any ingredients, known G6PD deficiency or phenylketonuria. - Patients with uncontrolled or untreated arterial hypertension - Pregnancy or lactating females - Patients who palpitation when drinking coffee - Clinical significant laboratory abnormalities or diseases which, in opinion of the investigator, placed the patient at risk or effect the study results.

Design outcomes

Primary

MeasureTime frame
Boston Bowel Preparation scale(BBPS) during colonoscopy Score to be categorized as 0-3 per segment(we will evaluate 3 segments ; right colon, transverse, le,efficacy new bowel preparation solution during colonoscopy Boston Bowel Preparation scale(BBPS)

Secondary

MeasureTime frame
safety, patient’s tolerance, willingness to repeat the same bowel preparation after colonoscopy Questionaire

Countries

Thailand

Contacts

Public ContactSUSRICHIT PHRUEKSOTSAI

Faculty of Medicine, Chiang Mai University

yosp205@gmail.com+66882766463

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026